Insulin absorption from lipodystrophic areas: A (neglected) source of trouble for insulin therapy?

Journal of Diabetes Science and Technology

Volumn 4, Issue 3, 2010, Pages 750-753

  Heinemann, Lutz ^a,b  

^a PROFIL Institut für Stoffwechselforschung   (Germany)

^b Profil Institute for Clinical Research   (United States)

Author keywords

Diabetes related complications; Insulin absorption; Insulin action; Insulin pharmacokinetics; Insulin therapy; Lipodystrophy

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

DIABETES MELLITUS; HUMAN; LIPODYSTROPHY; METABOLISM; REVIEW; SKIN;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPODYSTROPHY; SKIN;

EID: 78349286402     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400332     Document Type: Note

References (20)

1. Barak A, Har-Shai Y, Ullmann Y, Hirshowitz B. Insulin-induced lipohypertrophy treated by liposuction. Ann Plast Surg. 1996;37(4):415-7.
2. Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661-7.
3. Strauss K, De Gols H, Hannet I, Partanen TM, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int. 2002;19(3):71-6.
4. Swift B. Examination of insulin injection sites: an unexpected finding of localized amyloidosis. Diabet Med. 2002;19(10):881-6.
5. Wallymahmed ME, Littler P, Clegg C, Haqqani MT, MacFarlane IA. Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control. Postgrad Med J. 2004;80(950):732-3.
6. Galloway JA, Fireman P, Fineberg SE. Complications of insulin therapy: a brief overview of four years of experience with human insulin (rDNA). In: Raptis S, Church J, eds. Diabetes mellitus: achievements and scepticism. London: Royal Society of Medicine; 1984, 55-64.
7. Raile K, Noelle V, Landgraf R, Schwarz HP. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2001;109(8):393-6.
8. Roper NA, Bilous RW. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog). Diabet Med. 1998;15(12):1063-4.
9. Hauner H, Stockamp B, Haastert B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes. 1996;104(2):106-10.
10. Griffin ME, Feder A, Tamborlane WV. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause? Diabetes Care. 2001;24(1):174.
11. Ampudia-Blasco FJ, Hasbum B, Carmena R. A new case of lipoathrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications? Diabetes Care. 2003;26(3):953-4.
12. Hussein SF, Siddique H, Coates P, Green J. Lipoatrophy is a thing of the past, or is it? Diabet Med. 2007;24(12):1470-2.
13. Radermecker RP, Piérard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol. 2007;8(1):21-8.
14. Del Olmo MI, Campos V, Abellán P, Merino-Torres JF, Piñón F. A case of lipoatrophy with insulin detemir. Diabetes Res Clin Pract. 2008;80(1):e20-1.
15. Chowdhury TA, Escudier V. Poor glycaemic control caused by insulin induced lipohypertrophy. BMJ. 2003;327(7411):383-4.
16. Johansson UB, Amsberg S, Hannerz L, Wredling R, Adamson U, Arnqvist HJ, Lins PE. Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care. 2005;28(8):2025-7.
17. Kølendorf K, Bojsen J, Deckert T. Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients. Horm Metab Res. 1983;15(6):274-8.
18. Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJ. Diabetic lipohypertrophy delays insulin absorption. Diabetes Care. 1984;7(5):479-80.
19. Thow JC, Johnson AB, Marsden S, Taylor R, Home PD. Morphology of palpably abnormal injection sites and effects on absorption of isophane (NPH) insulin. Diabet Med. 1990;7(9):795-9.
20. Alemzadeh R, Loppnow C, Parton E, Kirby M. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther. 2003;5(2):167-73.